Morning Briefing
Summaries of health policy coverage from major news organizations
Report Identifies FDA's Weaknesses In Monitoring Foreign Drug Trials
The FDA inspected 0.7 percent of foreign clinical drug trial sites in 2008 while 80 percent of applications approved for marketing that year contained data from foreign drug trials, according to a report (.pdf) from the Inspector General of HHS, CBS News reports (Strickler, 6/22).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
